CFTR Inhibitors – MIMS – Risk of depression and related events
01/01/2024
Medicines for human use
Safety update
This article was produced by the HPRA for publication in the January/February edition of Monthly Index of Medical Specialities (MIMS) and highlights new warnings on the risk of depression and related events associated with the use of Kalydeco, Orkambi, Symkevi and Kaftrio.